Torthaí cuardaigh - David J. Lederer

Beachtaigh na torthaí
  1. 1
    Selecting lung transplant candidates: where do current guidelines fall short?

    Selecting lung transplant candidates: where do current guidelines fall short? de réir J.L. Hook, David J. Lederer

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Micromechanics of Alveolar Edema

    Micromechanics of Alveolar Edema de réir Carrie E. Perlman, David J. Lederer, Jahar Bhattacharya

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Screening High‐Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists

    Screening High‐Resolution Computed Tomography of the Chest to Detect Interstitial Lung Disease in Systemic Sclerosis: A Global Survey of Rheumatologists de réir Elana J. Bernstein, Dinesh Khanna, David J. Lederer

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Frailty in Pulmonary and Critical Care Medicine

    Frailty in Pulmonary and Critical Care Medicine de réir Jonathan P. Singer, David J. Lederer, Matthew R. Baldwin

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey

    Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey de réir Gregory P. Cosgrove, Pauline Bianchi, Sherry Danese, David J. Lederer

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Delayed Access and Survival in Idiopathic Pulmonary Fibrosis

    Delayed Access and Survival in Idiopathic Pulmonary Fibrosis de réir Daniela Lamas, Steven M. Kawut, Emilia Bagiella, Nisha Philip, Selim M. Arcasoy, David J. Lederer

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis

    Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis de réir David J. Lederer, Selim M. Arcasoy, Jessie S. Wilt, F. D’Ovidio, Joshua Sonett, Steven M. Kawut

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Hypoalbuminemia and Early Mortality After Lung Transplantation: A Cohort Study

    Hypoalbuminemia and Early Mortality After Lung Transplantation: A Cohort Study de réir Matthew R. Baldwin, Selim M. Arcasoy, Ashish S. Shah, P. Christian Schulze, Julia Sze, Joshua Sonett, David J. Lederer

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Vascular Inflammation in Obesity and Sleep Apnea

    Vascular Inflammation in Obesity and Sleep Apnea de réir Sanja Jelić, David J. Lederer, Tessa Adams, Margherita Padeletti, P.C. Colombo, Phillip Factor, Thierry H. Le Jemtel

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Sildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial

    Sildenafil for Chronic Obstructive Pulmonary Disease: A Randomized Crossover Trial de réir David J. Lederer, Matthew N. Bartels, Neil W. Schluger, Frances Brogan, Patricia Jellen, Byron Thomashow, Steven M. Kawut

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease

    Outcomes and Mortality Prediction Model of Critically Ill Adults With Acute Respiratory Failure and Interstitial Lung Disease de réir Whitney D. Gannon, David J. Lederer, Mauer Biscotti, Azka Javaid, Nina Patel, Daniel Brodie, Matthew Bacchetta, Matthew R. Baldwin

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells

    Modeling of Fibrotic Lung Disease Using 3D Organoids Derived from Human Pluripotent Stem Cells de réir Alexandros Strikoudis, Anna Cieślak, Lucas F. Loffredo, Ya‐Wen Chen, Nina Patel, Anjali Saqi, David J. Lederer, Hans-Willem Snoeck

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation

    Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation de réir David M. Vock, Michael T. Durheim, Wayne Tsuang, Catherine Copeland, Anastasios A. Tsiatis, Marie Davidian, Megan L. Neely, David J. Lederer, Scott M. Palmer

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial

    Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial de réir Toby M. Maher, Tamera J. Corte, Aryeh Fischer, Michael Kreuter, David J. Lederer, María Molina‐Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Vincent Cottin

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis

    Association of Angiotensin Modulators With the Course of Idiopathic Pulmonary Fibrosis de réir Michael Kreuter, David J. Lederer, María Molina‐Molina, Imre Noth, Claudia Valenzuela, Lutz Frankenstein, Derek Weycker, Mark Atwood, Klaus-Uwe Kirchgaessler, Vincent Cottin

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    A Prognostic Model for 6-Month Mortality in Elderly Survivors of Critical Illness

    A Prognostic Model for 6-Month Mortality in Elderly Survivors of Critical Illness de réir Matthew R. Baldwin, Wazim Narain, Hannah Wunsch, Neil W. Schluger, Joseph Cooke, Matthew J. Maurer, John W. Rowe, David J. Lederer, Peter B. Bach

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function

    Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function de réir Carlo Albera, Ulrich Costabel, Elizabeth A. Fagan, Marilyn K. Glassberg, Eduard Gorina, Lisa Lancaster, David J. Lederer, Steven D. Nathan, Dominique Spirig, Jeff Swigris

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Obesity and Underweight Are Associated with an Increased Risk of Death after Lung Transplantation

    Obesity and Underweight Are Associated with an Increased Risk of Death after Lung Transplantation de réir David J. Lederer, Jessie S. Wilt, F. D’Ovidio, Matthew Bacchetta, Lori Shah, Shankari Ravichandran, J. -L. J. Lenoir, Brenda Klein, Joshua Sonett, Selim M. Arcasoy

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2)

    Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and... de réir Toby M. Maher, Michael Kreuter, David J. Lederer, Kevin K. Brown, Wim Wuyts, Nadia Verbruggen, Simone Stutvoet, Ann Fieuw, Paul Ford, Walid Abi‐Saab, Marlies Wijsenbeek

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis

    Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis de réir Steven D. Nathan, Ulrich Costabel, Ian Glaspole, Marilyn K. Glassberg, Lisa Lancaster, David J. Lederer, Carlos A.C. Pereira, Benjamin Trzaskoma, Elizabeth Morgenthien, Susan L. Limb, Athol U. Wells

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: